GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

Satoe Fujiwara(Osaka University of Pharmaceutical Sciences), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Tomohito Tanaka, Hiroshi Kawaguchi(New Tokyo Hospital), Masaaki Takai(Osaka Medical and Pharmaceutical University), Yoshiki Yamashita(Osaka Medical and Pharmaceutical University), Yoshito Terai(Osaka Medical and Pharmaceutical University), Hiroshi Sasaki(Jikei University School of Medicine), Saha Yoo(Osaka Medical and Pharmaceutical University), Masanori Kanemura(Osaka Medical and Pharmaceutical University), Akiko Tanabe(Osaka Medical and Pharmaceutical University), Satoshi Tsunetoh(Osaka Medical and Pharmaceutical University), Yoshimichi Tanaka(Osaka Medical and Pharmaceutical University)
Journal of Ovarian Research
November 19, 2012
10.1186/1757-2215-5-35
Cited by 79

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Autophagy modulates osteoarthritis‐related gene expression in human chondrocytes
|Arthritis & Rheumatism|2011|265
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209